Jazz Pharmaceuticals
JAZZ
#2047
Rank
A$12.06 B
Marketcap
$198.69
Share price
1.00%
Change (1 day)
8.81%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2023 (TTM): -$2.00

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.26. In 2022 the company made an earnings per share (EPS) of -$5.67 an increase over its 2021 EPS that were of -$8.61.

EPS history for Jazz Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.00-64.62%
2022-$5.67-34.2%
2021-$8.61-224.83%
2020$6.90-53.25%
2019$14.7623.59%
2018$11.94-8.24%
2017$13.0123.74%
2016$10.5122.12%
2015$8.61478.49%
2014$1.49-74.93%
2013$5.94-27.11%
2012$8.1569.1%
2011$4.82245.98%
2010$1.39-462.5%
2009-$0.38-96.7%
2008-$11.65-27.04%
2007-$15.9765.47%
2006-$9.65-4.59%
2005-$10.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$6.43 185.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$13.27-687.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.99-365.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$3.20 41.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel